TURNOVER (x1000 NOK)
NET PROFIT (x1000 NOK)
EMPLOYEES
Rechon Life Science AB
Closing information (x1000 NOK)
Closing information | 2022/12 | 2021/12 | 2020/12 |
Turnover | 367,251 | 298,077 | 321,581 |
Financial expenses | 1,226 | 1,026 | 1,098 |
Earnings before taxes | 56,996 | 28,537 | 28,322 |
EBITDA | 73,626 | 42,183 | 39,355 |
Total assets | 309,265 | 276,639 | 227,902 |
Current assets | 159,166 | 131,078 | 144,110 |
Current liabilities | 75,502 | 51,868 | 62,386 |
Equity capital | 160,492 | 127,566 | 123,025 |
- share capital | 26,051 | 26,859 | 28,852 |
Employees (average) | 212 | 184 | 175 |
Financial ratios
Fiscal year | 2022/12 | 2021/12 | 2020/12 |
Solvency | 51.9% | 46.1% | 54.0% |
Turnover per employee | 1,732 | 1,620 | 1,838 |
Profit as a percentage of turnover | 15.5% | 9.6% | 8.8% |
Return on assets (ROA) | 18.8% | 10.7% | 12.9% |
Current ratio | 210.8% | 252.7% | 231.0% |
Return on equity (ROE) | 35.5% | 22.4% | 23.0% |
Change turnover | 78,132 | -1,286 | -9,362 |
Change turnover % | 27% | 0% | -3% |
Chg. No. of employees | 28 | 9 | 4 |
Chg. No. of employees % | 15% | 5% | 2% |
Total value of public sale
Fiscal year | 2022/12 | 2021/12 | 2020/12 |
Total value of public sale | 0 | 0 | 0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.